Although elevated LCN-2 expression was rarely reported in gastrointestinal cancer before, increased LCN-2 expression had been observed in other malignancies, including breast cancer, pancreatic cancer, and ovarian cancer17, 18. This evidence concerns the gene LCN2 and breast carcinoma.